UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

Zeitschrift für Gastroenterologie, 2022-09, Vol.60 (9), p.1346-1421

2022

Volltextzugriff (PDF)

Stabilisation of acute‐on‐chronic liver failure patients before liver transplantation predicts post‐transplant survival

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1502-1510

2018

Volltextzugriff (PDF)

Editorial: transplantation in the setting of acute‐on‐chronic liver failure—calculating chances. Authors’ reply

Alimentary pharmacology & therapeutics, 2018-07, Vol.48 (1), p.100-101

2018

Volltextzugriff (PDF)

A Randomized, Controlled Study to Assess the Conversion From Calcineurin‐Inhibitors to Everolimus After Liver Transplantation—PROTECT

American journal of transplantation, 2012-07, Vol.12 (7), p.1855-1865

2012

Volltextzugriff (PDF)

Everolimus and Early Calcineurin Inhibitor Withdrawal: 3‐Year Results From a Randomized Trial in Liver Transplantation

American journal of transplantation, 2014-03, Vol.14 (3), p.701-710

2014

Volltextzugriff (PDF)

The killer cell lectin‐like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation

HLA, 2018-01, Vol.91 (1), p.52-55

2018

Volltextzugriff (PDF)

Definition of Chronic Hepatitis E After Liver Transplant Conforms to Convention

American journal of transplantation, 2015-11, Vol.15 (11), p.3011-3012

2015

Volltextzugriff (PDF)

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation

Transplant infectious disease, 2016-06, Vol.18 (3), p.326-332

2016

Volltextzugriff (PDF)

High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study

United European gastroenterology journal, 2024-04, Vol.12 (3), p.339-351

2024

Volltextzugriff (PDF)

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting

Transplant infectious disease, 2015-08, Vol.17 (4), p.617-622

2015

Volltextzugriff (PDF)

P0748 : Course of HCV RNA and HCV core antigen testing are predictors for reaching SVR in transplant recipients

Journal of hepatology, 2015-04, Vol.62, p.S606-S607

2015

Volltextzugriff (PDF)

Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation

United European gastroenterology journal, 2018-02, Vol.6 (1), p.104-111

2018

Volltextzugriff (PDF)

Improvement in Gastrointestinal and Health-related Quality of Life Outcomes After Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Liver Transplant Recipients

Transplantation proceedings, 2014, Vol.46 (1), p.234-240

2014

Volltextzugriff (PDF)

P886 RELEVANCE OF CHRONIC HEPATITIS E IN LIVER TRANSPLANT RECIPIENTS: A REAL-LIFE-SETTING

Journal of hepatology, 2014-04, Vol.60 (1), p.S369-S370

2014

Volltextzugriff (PDF)

P875 FIRST CASE REPORT OF A PATIENT WITH FIBROSING CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION TREATED WITH SOFOSBUVIR AND SIMEPREVIR

Journal of hepatology, 2014-04, Vol.60 (1), p.S365-S365

2014

Volltextzugriff (PDF)

LP24 : Safety, efficacy and impact on liver function of simeprevir (SMV) in combination with daclatasvir (DCV) or sofosbuvir (SOF) in patients with severe hepatitis C recurrence after liver transplantation (LT): results from compassionate use in europe

Journal of hepatology, 2015-04, Vol.62, p.S275-S276

2015

Volltextzugriff (PDF)

P0596 : Association of hepatitis E virus and cryoglobulinemia

Journal of hepatology, 2015-04, Vol.62, p.S540-S540

2015

Volltextzugriff (PDF)

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting

Transplant infectious disease, 2016-02, Vol.18 (1), p.141-145

2016

Volltextzugriff (PDF)

O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn study

Journal of hepatology, 2015-04, Vol.62, p.S191-S192

2015

Volltextzugriff (PDF)

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E

Zeitschrift fur Gastroenterologie, 2015-07, Vol.53 (7), p.639

2015

Volltextzugriff (PDF)

Expert recommendations: Hepatitis C and transplantation

Zeitschrift fur Gastroenterologie, 2016-07, Vol.54 (7), p.665

2016

Volltextzugriff (PDF)

Naturally Occurring Variants of Hepatitis B Virus

Advances in Virus Research, 1999, Vol.52, p.25-137

1999

Volltextzugriff (PDF)

185 THE PROTECT STUDY: EVEROLIMUS MONOTHERAPY vs. CALCINEURIN INHIBITOR-BASED THERAPY RESULTS IN PROGRESSIVE RENAL FUNCTION BENEFIT OVER 35 MONTHS IN LIVER TRANSPLANT RECIPIENTS

Journal of hepatology, 2013-04, Vol.58, p.S82-S82

2013

Volltextzugriff (PDF)

958 EXTRAHEPATIC MALIGNANCIES AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A LONG-TERM FOLLOW-UP OBSERVATIONAL STUDY OF A LARGE, MULTICENTER COHORT

Journal of hepatology, 2013-04, Vol.58, p.S395-S395

2013

Volltextzugriff (PDF)

Alkoholassoziierte Lebererkrankung – Indikationsstellung und Management auf der Warteliste

Verdauungskrankheiten, 2023-03, Vol.41 (3), p.69-81

2023

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

Stabilisation of acute‐on‐chronic liver failure patients before liver transplantation predicts post‐transplant survival

Editorial: transplantation in the setting of acute‐on‐chronic liver failure—calculating chances. Authors’ reply

A Randomized, Controlled Study to Assess the Conversion From Calcineurin‐Inhibitors to Everolimus After Liver Transplantation—PROTECT

Everolimus and Early Calcineurin Inhibitor Withdrawal: 3‐Year Results From a Randomized Trial in Liver Transplantation

The killer cell lectin‐like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation

Definition of Chronic Hepatitis E After Liver Transplant Conforms to Convention

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation

High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting

P0748 : Course of HCV RNA and HCV core antigen testing are predictors for reaching SVR in transplant recipients

Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation

Improvement in Gastrointestinal and Health-related Quality of Life Outcomes After Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Liver Transplant Recipients

P886 RELEVANCE OF CHRONIC HEPATITIS E IN LIVER TRANSPLANT RECIPIENTS: A REAL-LIFE-SETTING

P875 FIRST CASE REPORT OF A PATIENT WITH FIBROSING CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION TREATED WITH SOFOSBUVIR AND SIMEPREVIR

LP24 : Safety, efficacy and impact on liver function of simeprevir (SMV) in combination with daclatasvir (DCV) or sofosbuvir (SOF) in patients with severe hepatitis C recurrence after liver transplantation (LT): results from compassionate use in europe

P0596 : Association of hepatitis E virus and cryoglobulinemia

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting

O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn study

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E

Expert recommendations: Hepatitis C and transplantation

Naturally Occurring Variants of Hepatitis B Virus

185 THE PROTECT STUDY: EVEROLIMUS MONOTHERAPY vs. CALCINEURIN INHIBITOR-BASED THERAPY RESULTS IN PROGRESSIVE RENAL FUNCTION BENEFIT OVER 35 MONTHS IN LIVER TRANSPLANT RECIPIENTS

958 EXTRAHEPATIC MALIGNANCIES AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A LONG-TERM FOLLOW-UP OBSERVATIONAL STUDY OF A LARGE, MULTICENTER COHORT

Alkoholassoziierte Lebererkrankung – Indikationsstellung und Management auf der Warteliste

Aktive Filter

Suchergebnisse filtern